Mirabella Financial Services LLP Rhythm Pharmaceuticals, Inc. Transaction History

Mirabella Financial Services LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $304,025 - $616,696	18,011 Added 156.77%	29,500 $526,000
Q4 2022 Feb 13, 2023	BUY	$22.21 - $30.25 $255,170 - $347,542	11,489 New	11,489 $334,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $32,853 - $128,992	-10,530 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$6.13 - $12.24 $64,548 - $128,887	10,530 New	10,530 $121,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.